A dozen of New England’s brightest emerging scientists gathered today at University of New England to celebrate a unique student research and entrepreneurship program now in its second year. The...
(PRWeb July 31, 2012)
Read the full story at http://www.prweb.com/releases/2012/7/prweb9757471.htm
Phase II award will fund development of novel microfluidic platform for aptamer discovery.
(PRWeb July 31, 2012)
Read the full story at http://www.prweb.com/releases/2012/7/prweb9757330.htm
Burns Series 100 Special Limits of Error Thermocouples are Designed for Rugged Conditions and Provide Maximum Performance and Service Life. Updated with New Content, Options and Images, This Catalog...
(PRWeb July 31, 2012)
Read the full story at http://www.prweb.com/releases/Thermocouple/Catalog/prweb9753442.htm
Burns Series 200 & 300 RTDs are Designed to Meet “Real World” Conditions and Provide the Highest Levels of Temperature Measurement Accuracy. Updated with New Content, Options and Images, This...
(PRWeb July 31, 2012)
Read the full story at http://www.prweb.com/releases/Series100/Catalog/prweb9752167.htm
Burns Series 200 & 300 RTDs are Designed to Meet “Real World” Conditions and Provide the Highest Levels of Temperature Measurement Accuracy. Updated with New Content, Options and Images, This...
(PRWeb July 31, 2012)
Read the full story at http://www.prweb.com/releases/Series100/Catalog/prweb9752167.htm
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
Recent Comments